Chemours Stock Earnings Reports

Key points for investors: Chemours reported a stronger-than-expected Q1 2026 driven by standout performances in Thermal & Specialized Solutions (TSS) and Titanium Technologies (TT). TSS delivered record results with double-digit year-over-year growth in refrigerants (Freon and Opteon), strong quota execution, and expanded margins (~33% in the quarter). TT exceeded earnings expectations primarily via global pricing actions and cost management despite mixed volume trends across regions. Advanced Performance Materials (APM) was negatively impacted by the Washington Works outage and the prior closure of an SPS Capstone line, which drove a ~ $25 million EBITDA headwind in Q1, but order momentum (notably in semiconductors and data centers) positions APM for improvement later in 2026. Balance sheet progress: near-complete sale of Kuan Yin land (remaining parcel expected to net ~$60M gross), ~$160M of near-term debt repaid, and a $700M refinancing extending maturities to 2034—management expects net leverage below ~3.8x adjusted EBITDA by year-end and continued debt paydowns. Q2 / near-term guidance: consolidated sequential net sales growth of ~15–20% and consolidated adjusted EBITDA of $220–$250M; segment-level Q2 guides include TSS EBITDA ~$210–$225M, TT EBITDA $40–$50M, APM EBITDA $12–$18M. Capital expenditures for Q2 are expected ~$50M and Q2 free cash flow at least $100M; full-year free cash flow conversion now expected above 20% (lower than prior 25% guidance due to tax treatment of land-sale proceeds). Risks and watch items: softer-than-expected residential HVAC (OEM) demand that may temper TSS seasonality, ongoing geopolitical uncertainty (Middle East) and sulfur cost inflation affecting TiO2 industry cost dynamics, and operational/outage risks (e.g., Corpus Christi water curtailment scenario already incorporated). Management emphasizes disciplined quota allocation, pricing execution, operational reliability improvements, and continuing focus on margin and cash generation.